Insulin Resistance: 7 Surprising Ways It Drives Your PCOS Symptoms
This article is for informational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider for personalized guidance.
Insulin Resistance: 7 Surprising Ways It Drives Your PCOS Symptoms
If you have PCOS, you may have heard the term insulin resistance during a doctor’s visit or while looking up your symptoms online. It can sound technical, but it is one of the most important parts of the PCOS story.
For many people, insulin resistance is the hidden driver connecting symptoms that seem unrelated, irregular periods, acne, fatigue, and weight changes. Major health organizations and clinical guidance describe insulin resistance as a central feature of PCOS for many patients, even though it does not affect everyone in the same way (Centers for Disease Control and Prevention [CDC], 2024; Teede et al., 2023). Here are seven surprising ways insulin resistance drives your PCOS symptoms.
Understanding insulin resistance is not about blame. It is about understanding one body system that may be driving several symptoms at once.
What insulin does in the body
Insulin is a hormone made by the pancreas. Its main job is to help move glucose, or sugar, from the blood into cells so the body can use it for energy.
When the body responds well to insulin, blood sugar stays in a healthy range. When the body becomes insulin-resistant, cells do not respond as well to insulin as they should. To keep blood sugar under control, the pancreas makes more insulin. That leads to higher insulin levels. The CDC explains that many people with PCOS make insulin but cannot use it effectively (CDC, 2024).
That extra insulin does more than affect blood sugar. PCOS can also affect hormone production.
Why insulin resistance matters so much in PCOS
Research shows that insulin resistance is common in PCOS, including in many people who are not overweight. It is often worse when obesity is present, especially with more abdominal fat, but it is not simply a weight issue. Research reviews describe insulin resistance in PCOS as partly tied to underlying biology, not just body size (Saadati et al., 2025; Zhao et al., 2023).
This matters because insulin resistance sits at the crossroads of the metabolic and hormonal sides of PCOS.
Higher insulin levels can:
- push the ovaries to make more androgens, such as testosterone
- lower the liver’s production of sex hormone-binding globulin, or SHBG
- increase the amount of free androgen circulating in the blood
- make ovulation less regular
- worsen the cycle of irregular periods and symptoms over time
Clinical evidence supports this insulin-androgen link as one of the main mechanisms underlying the progression of PCOS symptoms (Diamanti-Kandarakis & Dunaif, 2012; Saadati et al., 2025; Šikonja et al., 2023).
The insulin-androgen loop
One of the simplest ways to understand PCOS is to think of it as a loop.
- The body becomes less responsive to insulin.
- The pancreas makes more insulin to compensate.
- High insulin levels signal the ovaries to make more androgens.
- Higher androgen levels can disrupt ovulation and menstrual cycles.
- Androgen excess can also worsen insulin resistance over time.
That loop can drive many of the symptoms people notice first, including:
- Irregular or missed periods
- acne
- excess facial or body hair
- scalp hair thinning
- weight gain or difficulty managing weight
- fatigue and energy crashes
- increased risk of prediabetes or type 2 diabetes
Major health organizations describe PCOS as involving both hormone imbalance and metabolic changes, which is why symptoms can show up across the whole body (CDC, 2024; World Health Organization [WHO], 2026).
Can you have insulin resistance in PCOS if you are not overweight?
Yes.
This is one of the most important points for readers to understand. Insulin resistance is more common and often more severe in people with PCOS who also have obesity, but it can also occur in people with smaller bodies. Lean PCOS does not always mean low metabolic risk (Diamanti-Kandarakis & Dunaif, 2012; Zhao et al., 2023).
That means someone can look healthy from the outside and still have insulin resistance, irregular ovulation, or abnormal blood sugar handling. This is one reason some people with PCOS are diagnosed late or do not get the screening they need. Current guidance also emphasizes that PCOS care is often delayed and incomplete (Teede et al., 2023).
How insulin resistance can show up in daily life
Insulin resistance does not always cause obvious symptoms at first. Some people only find out after blood work. Others notice patterns before they ever see a lab result.
Possible signs or related concerns can include:
- fatigue, especially after eating
- strong cravings or frequent hunger
- weight gain, especially around the abdomen
- darkened skin in folds such as the neck or underarms
- Higher triglycerides or lower HDL cholesterol
- Rising blood sugar over time
- Worsening acne, or excess hair growth, along with cycle problems
These signs are not unique to PCOS, and they do not prove someone has insulin resistance. But they can be clues worth discussing with a clinician, especially because PCOS is linked with higher diabetes risk and other chronic health concerns (CDC, 2024; WHO, 2026).
How Insulin Resistance Affects Long-Term Health
PCOS is often framed as a fertility condition, but that is too narrow. Insulin resistance is one reason PCOS is also viewed as a metabolic health condition.
The CDC notes that more than half of women with PCOS develop type 2 diabetes by age 40. WHO describes PCOS as a condition that affects women during their reproductive years and beyond, and links it with insulin resistance, obesity, and type 2 diabetes risk (CDC, 2024; WHO, 2026).
This is a relatively recent shift. For years, PCOS was framed mainly as a reproductive condition, but newer guidance emphasizes its metabolic and lifelong health impact. That broader framing matters because it supports earlier screening, prevention, and follow-up instead of waiting until fertility becomes the main concern (Teede et al., 2023; WHO, 2026).
Health agencies and reviews note that PCOS is linked with higher risks of:
- prediabetes
- type 2 diabetes
- unhealthy cholesterol patterns
- fatty liver disease
- metabolic syndrome
- Higher cardiovascular risk over time
This does not mean everyone with PCOS will develop these conditions. It means there is enough evidence to support early screening and ongoing follow-up (CDC, 2024; Teede et al., 2023).
How clinicians evaluate insulin resistance in PCOS
There is no single perfect test for insulin resistance in routine care.
In research settings, insulin resistance can be measured in very detailed ways. In real-world care, clinicians usually use a mix of tools instead, such as:
- fasting glucose
- hemoglobin A1c
- an oral glucose tolerance test
- lipid panels
- blood pressure
- weight or waist trends
- symptom history and family history
Current guidance emphasizes regular glycemic assessment in PCOS because diabetes risk is increased. Which tests make the most sense can depend on age, symptoms, pregnancy status, and other risk factors (CDC, 2024; Teede et al., 2023).
What can help improve insulin resistance in PCOS?
There is no one-size-fits-all treatment, but insulin resistance can often improve.
1. Lifestyle changes that are realistic
Health experts recommend lifestyle support as a first step for many people with PCOS. That usually includes nutrition, physical activity, sleep, and stress care.
This does not mean crash diets or punishing exercise.
Research and guidelines support sustainable habits that improve insulin sensitivity and overall health, such as:
- regular movement you can stick with
- balanced meals with enough protein and fiber
- fewer highly refined carbohydrates when possible
- consistent sleep habits
- stress management and mental health support
Even modest weight loss may improve insulin sensitivity and ovulation for some people, but care should not become shame-based or weight-only. People of all sizes deserve metabolic support (Teede et al., 2023; WHO, 2026).
2. Metformin
Metformin is one of the best-known medicines used in PCOS, especially when insulin resistance, prediabetes, or cycle irregularity is part of the picture.
Health agencies note that metformin can help the body use insulin more effectively and may improve menstrual regularity and ovulation in some patients. A 2025 review also describes benefits for insulin resistance and metabolic and reproductive features in selected patients. It is not a cure, and it is not right for everyone. Some people do well with it, while others need a different plan (Office on Women’s Health [OWH], 2025; Saadati et al., 2025).
3. Support for the full picture
Because insulin resistance connects with hormones, mood, sleep, and cardiometabolic health, treatment often works best when it is not limited to one symptom.
Good PCOS care may include:
- help with cycle regulation
- screening for diabetes and cholesterol problems
- support for acne or excess hair growth
- sleep evaluation when needed
- mental health support
- fertility care if pregnancy is a goal
This whole-body approach matches how current health bodies describe PCOS care (OWH, 2025; Teede et al., 2023; WHO, 2026).
Common myths about insulin resistance in PCOS
Myth 1: Only people with obesity get insulin resistance
Not true. Obesity can worsen insulin resistance, but many lean people with PCOS also have it (Diamanti-Kandarakis & Dunaif, 2012; Zhao et al., 2023).
Myth 2: Insulin resistance only affects blood sugar
Not true. In PCOS, insulin can also influence androgen production, ovulation, and symptom severity (Diamanti-Kandarakis & Dunaif, 2012; Saadati et al., 2025).
Myth 3: If your period is the main issue, blood sugar does not matter
Not true. Irregular periods and metabolic risk can be linked through insulin resistance, which is why screening is still important (CDC, 2024; Teede et al., 2023).
Myth 4: Metformin fixes PCOS for everyone
Not true. Metformin helps some people, but PCOS treatment should be individualized (OWH, 2025; Saadati et al., 2025).
Practical takeaways
If you have PCOS and think insulin resistance may be part of the picture, these steps can help:
- Ask your clinician what screening makes sense for blood sugar and cholesterol
- Track symptoms like fatigue, cravings, cycle changes, and skin changes
- Focus on steady habits rather than extreme fixes
- Ask whether metformin or another support option makes sense for you
- Remember that insulin resistance can matter even if you are not overweight
Why this conversation matters
Insulin resistance is one of the main reasons PCOS is more than a reproductive condition. It helps connect the dots between hormones, periods, blood sugar, energy, and long-term health risk. Major health bodies now reflect this broader view of PCOS (CDC, 2024; Teede et al., 2023; WHO, 2026).
That matters because people with PCOS often get fragmented advice. One visit may focus on acne. Another may focus on fertility. Another may focus only on weight.
But the body does not work in separate boxes.
A clearer understanding of insulin resistance helps explain why symptoms can feel so connected. It also supports a better model of care: earlier screening, more practical lifestyle support, and treatment that matches a person’s actual risks and goals (Teede et al., 2023).
See also:
See also: PCOS: 7 Surprising Ways It Affects Your Health Beyond Fertility.
FAQ
Is insulin resistance common in PCOS?
Yes. Health agencies and research reviews describe insulin resistance as common in PCOS, though it does not affect everyone to the same degree (CDC, 2024; Zhao et al., 2023).
Can you have PCOS-related insulin resistance if you are thin?
Yes. It may be more common with obesity, but it can also occur in lean PCOS (Diamanti-Kandarakis & Dunaif, 2012; Zhao et al., 2023).
Does insulin resistance cause high testosterone in PCOS?
Research supports a strong connection. High insulin levels can stimulate ovarian androgen production and lower SHBG, thereby increasing free androgen levels (Diamanti-Kandarakis & Dunaif, 2012; Saadati et al., 2025).
Will metformin cure insulin resistance in PCOS?
No. Metformin can help some people, but it is one tool, not a cure. Treatment should be individualized (OWH, 2025; Saadati et al., 2025).
Save this article so you can refer back to it and share it with someone who needs a clearer explanation of insulin resistance in PCOS. Then talk with a qualified healthcare provider about screening, symptoms, and treatment options that fit your goals.
This article is for informational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider for personalized guidance.
References
Centers for Disease Control and Prevention. (2024, May 15). Diabetes and polycystic ovary syndrome (PCOS). https://www.cdc.gov/diabetes/risk-factors/pcos-polycystic-ovary-syndrome.html
Diamanti-Kandarakis, E., & Dunaif, A. (2012). Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. Endocrine Reviews, 33(6), 981–1030. https://doi.org/10.1210/er.2011-1034
Office on Women’s Health. (2025, October 24). Polycystic ovary syndrome. U.S. Department of Health and Human Services. https://womenshealth.gov/a-z-topics/polycystic-ovary-syndrome
Saadati, S., Mason, T., Godini, R., Vanky, E., Teede, H., & Mousa, A. (2025). Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges. Diabetes, Obesity and Metabolism, 27(Suppl. 3), 31–47. https://doi.org/10.1111/dom.16422
Šikonja, J., Herman, R., Janež, A., Jensterle, M., & Dolžan, V. (2023). Insulin metabolism in polycystic ovary syndrome: Secretion, signaling, and clearance. International Journal of Molecular Sciences, 24(4), 3140. https://doi.org/10.3390/ijms24043140
Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., Norman, R. J., Mousa, A., Joham, A. E., International PCOS Network, Ee, C., & Avery, J. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 108(10), 2447–2469. https://doi.org/10.1210/clinem/dgad463
World Health Organization. (2026, January 22). Polycystic ovary syndrome. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
Zhao, H., Zhang, J., Cheng, X., et al. (2023). Insulin resistance in polycystic ovary syndrome across various tissues: An updated review of pathogenesis, evaluation, and treatment. Journal of Ovarian Research, 16, 9. https://doi.org/10.1186/s13048-022-01091-0
